Assessment of Residual or Resected Disappearing Liver Metastases After Chemotherapy
Approximately 10% of DLM harbored residual disease. These findings support selective resection strategies based on intraoperative findings and highlight the importance of precise imaging and postoperative surveillance.
Authors
- Sho Kiritani
- Takashi Akiyoshi (ORCID: https://orcid.org/0000-0002-2321-1412)
- Kosuke Kobayashi (ORCID: https://orcid.org/0000-0002-5144-351X)
- Atsushi Oba (ORCID: https://orcid.org/0000-0002-7315-0830)
- Hiromichi Ito (ORCID: https://orcid.org/0000-0003-0941-2055)
- Tomohiro Yamaguchi (ORCID: https://orcid.org/0000-0001-6548-856X)
- Yu Takahashi (ORCID: https://orcid.org/0000-0003-3066-023X)
- Hiroki Osumi (ORCID: https://orcid.org/0000-0002-4742-0446)
- Naoki Miyazaki (ORCID: https://orcid.org/0000-0001-7753-5191)
- Eiji Shinozaki (ORCID: https://orcid.org/0000-0002-7448-5894)
- Yosuke Inoue (ORCID: https://orcid.org/0000-0002-9285-9255)
- Noriyuki Ishida (ORCID: https://orcid.org/0000-0003-2826-6567)
- Kensei Yamaguchi (ORCID: https://orcid.org/0000-0001-6887-5709)
- Yoshihiro Ono
- Takafumi Sato (ORCID: https://orcid.org/0009-0004-6086-3462)
Institutions
- Obayashi (Japan) (JP)
- Asahi Kasei (Germany) (DE)
- Takahashi Industrial and Economic Research Foundation (JP)
- Japanese Foundation For Cancer Research (JP)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1097/sla.0000000000006923
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32